載入...
Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
Ivermectin (Mectizan(®)) is the only drug currently recommended for the treatment and control of onchocerciasis. Serious adverse events rarely occur during treatment, except in subjects heavily infected with Loa Loa. This review of drug-related serious adverse events in the treatment of onchocercias...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2003
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2147654/ https://ncbi.nlm.nih.gov/pubmed/14975063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2883-2-S1-S6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|